Choose a country to view content specific to your location
Rubeola (also known as measles) is a highly contagious viral infection of the respiratory system, immune system, and skin. It is caused by a paramyxovirus of the genus Morbillivirus. The disease kills more than 100,000 people a year, most under the age of 5.
Contact us to learn more about Meridian’s molecular or immunoassay reagent portfolio. We want to hear from you!
| Name | Type | Format | Host/Source | Isotype | Tested Apps | Unit | Catalog | Buffer | Immunogen | Recombinant | Description | Notes | Safety Data Sheet | COA/Test Release | Product Information Sheet | New Product | Recommended Product | Order a Sample | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rubeola antigen | Antigen | Partially Purified | Vero Cells | N/A | EIA,CLI | ML | 7604 | No | Safety Data Sheet — | COA/Test Release | — | 0 | 0 | |||||||
| Rubeola Nucleoprotein Ag Recom | Antigen | Purified | Sf9 CELLS (INSECT) | N/A | WB,EIA,CLI | MG | EV9298 | Yes | Safety Data Sheet — | COA/Test Release | — | 0 | 0 | |||||||
| MAb to Measles Virus | Monoclonal | Purified | Mouse | IgG | EIA,IFA | MG | C01723M | No | Safety Data Sheet — | COA/Test Release | — | 0 | 0 | |||||||
| MAb to Measles Virus | Monoclonal | Purified | Mouse | IgG | EIA,IFA | MG | C01724M | No | Safety Data Sheet — | COA/Test Release | — | 0 | 0 | |||||||
| MAb to Measles Virus | Monoclonal | Purified | Mouse | IgG | EIA,IFA | MG | C01725M | No | Safety Data Sheet — | COA/Test Release | — | 0 | 0 | |||||||
| MAb to Measles Virus | Monoclonal | Purified | Mouse | IgG | EIA,IFA | MG | C01726M | No | Safety Data Sheet — | COA/Test Release | — | 0 | 0 |
Not seeing what you’re looking for? Inquire about a new product
Measles is the leading cause of vaccine-preventable childhood mortality. The classic signs and symptoms of measles include a high fever, coughing, conjunctivitis and a characteristic rash. Symptoms usually develop 7–14 days after exposure and 3 out of 10 people who get measles will develop one or more complications including pneumonia, encephalitis and death. There is no specific treatment for measles although in developed countries, children are immunized against measles at 12 months old as part of a three-part Measles, Mumps and Rubella (MMR) vaccine. A recent increase in measles worldwide has been driven by unvaccinated people spreading the disease into countries where it was once declared eliminated. Measles is extremely infectious and among unimmunized people exposed to the virus, over 90% will contract the disease.
Measles-specific IgM detection using ELISA indirect capture methods or measles IgM capture are the standard tests for rapid laboratory diagnosis of measles. However, in regions where endemic measles has been eliminated, additional diagnostic assays are used to confirm measles cases irrespective of vaccination status. IgG avidity testing has proved useful in cases that require additional methods, such as suspected false negatives or false positives.
Have questions about a product? Want to learn more about Meridian’s molecular or immunoassay reagent portfolio? We want to hear from you!
By submitting your information in this form, you agree that your personal information may be stored and processed in any country where we have facilities or service providers, and by using our “Contact Us” page you agree to the transfer of information to countries outside of your country of residence, including to the United States, which may provide for different data protection rules than in your country. The information you submit will be governed by our Privacy Statement.
| Type |
|---|
| Format |
| Host/Source |
| Isotype |
| Tested Apps |
| Unit |
| Catalog |
| Buffer |
| Immunogen |
| COFA Description |
| COFA Notes |
| Recombination |
| SDS |
| COA |
| Product Information Sheet |
| Request Sample |